Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Major Shareholding Notification 2014

Jul 25, 2014

4797_mrq_2014-07-25_3178c844-02cd-474a-89b3-d20713cf17b7.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3872N

Dechra Pharmaceuticals PLC

25 July 2014

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii
DECHRA PHARMACEUTICALS PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the

notification obligation: iii
FMR LLC
4. Full name of shareholder(s) (if different from 3.):iv See Section 9
5. Date of the transaction and date on

which the threshold is crossed or

reached: v
24th July 2014
6. Date on which issuer notified: 25th July 2014
7. Threshold(s) that is/are crossed or

reached: vi, vii
10%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of

shares



if possible using

the ISIN CODE
Situation previous

to the triggering

transaction
Resulting situation after the triggering transaction
Number

of

Shares
Number

of

Voting

Rights
Number

of shares
Number of voting

rights
% of  voting rights x
Indirect Direct xi Indirect xii Direct Indirect
GB0009633180 8,776,091 8,776,091 8,761,091 8,761,091 9.98%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial

instrument
Expiration

date xiii
Exercise/

Conversion Period xiv
Number of voting

rights that may be

acquired if the

instrument is

exercised/ converted.
% of voting

rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial

instrument
Exercise price Expiration date xvii Exercise/

Conversion period xviii
Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
8,761,091 9.98%

9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable: xxi

Custodian Day to Day IM Total
BROWN BROTHERS HARRIMAN AND CO FMRC-FMR CO., INC 4,575,833
JPMORGAN CHASE BANK FMR UK-FIDELITY MANAGEMENT & RESEARCH (U.K.) INC. 438,095
FMRC-FMR CO., INC 1,170,800
NORTHERN TRUST CO (C) FMRC-FMR CO., INC 415,700
STATE STREET BANK AND TR CO FMRC-FMR CO., INC 2,160,663
Grand Total 8,761,091

Proxy Voting:

10. Name of the proxy holder:

FMR LLC

11. Number of voting rights proxy holder will cease to hold:

15,000

12. Date on which proxy holder will cease to hold voting rights:

24th July 2014

13. Additional information:

None

14. Contact name:

Nina Collomosse

15. Contact telephone number:

[email protected], 01737 837092

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFMGZNFKMGDZM